Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Talabostat mesylate |
Trade Name | |
Synonyms | BXCL701|PT 100|PT-100 |
Drug Descriptions |
Talabostat mesylate (BXCL701) is a dipeptidyl peptidase inhibitor that may activate T and NK cells and enhance antitumor immune reaction (J Clin Onco 36, no. 15_suppl (May 20 2018) 3085-3085). |
DrugClasses | |
CAS Registry Number | 150080-09-4 |
NCIT ID | C80682 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + Talabostat mesylate | Pembrolizumab Talabostat mesylate | 0 | 3 |
Talabostat mesylate | Talabostat mesylate | 0 | 2 |